Zoekresultaten - You searched for Research

338 results

Helena Biosciences to develop automated blood test for chronic liver disease based on VIB and Ghent University research

Read more

So hot it hurts - Leuven researchers uncover ion channel trio that mediates painful heat sensing

Read more

Scientists pinpoint surprising origin of melanoma

Read more

Imec Designs and Fabricates World-First Miniature Neural Probe for Simultaneous Recording of Multiple Brain Regions at Neuronal Resolution

Read more

Scientists shed light on a tumor-suppressive protein In metastases

Read more

Imec’s SWEET study Collects World’s Largest Dataset on Stress Detection

Read more

Closing in on Tau: Researchers identify a new synaptic player in early stages of neurodegeneration

Read more

European Union provides Biocartis with up to EUR 24m debt financing facility for infectious disease projects

Read more

Imec demonstrates direct optical reading of single-molecule DNA bases in modified nanopores

Read more

ProDigest: PROMISE

Read more

Imec demonstrates compact low-power 140GHz CMOS radar with on-chip antennas

Read more

Rejuvenate Biomed awarded €460,000 grant from VLAIO to accelerate drug development for healthy aging

Read more

Imec to Honor Samsung’s Dr. Kinam Kim With “Lifetime of Innovation Award”

Read more

ThromboGenics NV : New ThromboGenics Ophthalmic Research Findings Presented at ARVO 2017 Annual Vision Research Meeting in Baltimore

Read more

VIB: A new unexpected key player in melanoma development identified

Read more

VIB: Researchers identify nutrient metabolism that drives breast tumor metastasis

Read more

Tau prevents synaptic transmission at early stage of neurodegeneration

Read more

Scientists give tumor-fighting cells a boost in battling bone marrow cancer

Read more

Biocartis Group NV: MRC Technology and Biocartis initiate development of liquid biopsy test for breast cancer

Read more

Researchers gain new insights into the formation of non-pathological amyloids

Read more

Unchained Labs acquires Trinean

Read more

Novel perspectives on anti-amyloid treatment for the prevention of Alzheimer’s disease

Read more

Imec Reports Micro-Optomechanical Pressure Sensor Advancing Pressure Monitoring in Biomedical Applications

Read more

Imec Leverages the Power of Silicon Fabrication to Create Innovative Neural Probe Demonstrator with Unprecedented Electrode Density

Read more

Count your blessings: Quantitative Microbiome Profiling

Read more

New at Poulpharm: Animal facility for studies demanding high-containment levels

Read more

Confo Therapeutics enters into drug discovery collaboration with Roche

Read more

Ablynx appoints dr. Robert Friesen as Chief Scientific Officer

Read more

New collaboration between VIB and Plant Impact plc: advancing crop enhancement small molecule discovery

Read more

CMAST supports Rejuvenate Biomed in their search for ways to impact the ageing process

Read more

Research and innovation on monitoring and control of infectious diseases (One Health)

Read more

VIB Plant-derived volatiles may serve as future antifungals

Read more

European scientists unite to track all cells in the human body

Read more

CoBioRes receives a € 1.7M grant from VLAIO to support its tetrapeptide prodrug research for treatment of Triple Negative Breast Cancer

Read more

VIB: New genes found only in humans shed light on unique features of brain development

Read more

Microbiome pioneer S-Biomedic secures investment and collaboration with global skin care company beiersdorf

Read more

Scientists expose protein responsible for allergic diseases

Read more

Applied Bioinformatics in Life Sciences (2nd edition)

Read more

REVERSED BREXIT: £250 MILLION FOR BART DE STROOPER'S DEMENTIA RESEARCH

Read more

Biogazelle offers unique mRNA sequencing on plasma

Read more

MDxHealth and Maastricht University Collaborate on Next Generation (Epi)genetic Cancer Diagnostics

Read more

VIB: Shortage of progranulin is a frequent cause of frontotemporal dementia

Read more

500 vacancies in the Flemish biotech sector

Read more

Researchers discover mechanism behind rapid smell source localization

Read more

Cell Death and Immunity in Disease: from molecules to translational medicine

Read more

Visionary seminar: 'Regenerative Medicine: Growing the Future'

Read more

Advanced Materials for Biomedical Applications conference

Read more

bionection – Partnering Conference for Technology Transfer in Life Sciences

Read more

The annual CRIG industrial partnering event

Read more

Ablynx & Sanofi enter into a strategic collaboration to develop nanobody product candidates

Read more

ELIXIR Innovation and SME Forum: Data-driven innovation in food, nutrition and the microbiome

Read more

MDxHealth Opens New Service and Research Laboratory in The Netherlands

Read more

ONTOFORCE wins the EIT Venture Award 2017

Read more

Newly described process in Parkinson’s protein as a potential new therapy route

Read more

Bridging Preclinical and Clinical Development

Read more

ThromboGenics Business Update - Q3 2017

Read more

Mithra and Adamed Sign Commercialization Agreement for MyringTM in the Czech Republic

Read more

Seminar: How Real World Data will change your clinical development to the better

Read more

HDAC6 inhibitors protect against neuronal damage and have therapeutic potential in both neurology and oncology

Read more

new England biolabs® and Bluebee partner to deliver an end-to-end data analysis solution for Nebnext direct® target enrichment

Read more

Imec Introduces CMOS Chip With 16,384 Micro-electrodes and 1,024 Channels for Multimodal Cell Interfacing

Read more

Imec.istart is ranked fourth in UBI Global’s University Business Accelerator ranking

Read more

Argenx awarded €2.5 million VLAIO grant to identify novel therapeutic antibodies

Read more

Argenx announces expansion of its pipeline with addition of complement-targeted ARGX-117 for treatment of severe autoimmune diseases

Read more

DuPont and Inbiose Celebrate EU Regulatory Approval of Their First Human Milk Oligosaccharide Ingredient for Infant Formula

Read more

argenx to receive third preclinical milestone payment from collaboration with LEO Pharma

Read more

Agilent Technologies to Enhance Lab Informatics with Acquisition of Genohm

Read more

Do you have to become officially a BIOBANK under the new Belgian law?

Read more

Mithra announces further positive phase IBB Donesta® efficacy and safety data

Read more

CMAST attends the 2nd General Assembly of RESCEU; a European project focusing on the battle against RSV (June 21st-22nd, Oxford - UK)

Read more

Flanders Vaccine

Read more

flanders.bio provides you with insights in the vibrant life sciences sector

Read more

CMAST: Horizon Europe – looking at the future or building on the past?

Read more

Reverse Science Café: What are biobanks?

Read more

VIB and DNAlytics team up to develop non-invasive Colorectal Cancer screening test

Read more

MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology

Read more

VIBes in Biosciences - International Symposium for PhD students in Life Sciences

Read more

ThromboGenics Achieves Important Milestone in the Development of THR-149

Read more

Esperite N.V. with CryoSave contributes to treating a 9 year old child with thalassema major in Switzerland

Read more

ONTOFORCE and Ghent University launch a new innovative ‘text mining’ project

Read more

SLims by Genohm integrated with Pathomation’s PMA.core

Read more

Mithra & Gynial sign commercialization agreement for MyringTM in Austria

Read more

ThromboGenics NV to present THR-317 Pre-clinical Research Findings

Read more

Mithra Obtains Marketing Authorization for Tibelia® in France

Read more

International Course: Principles of Biosafety

Read more

Mithra Signs Exclusive Agreement for Tibelia® in Canada

Read more

Mithra Receives Orphan Drug Designation from EMA for E4 in Neonatal Encephalopathy

Read more

Belgium showcases expertise on Immunotherapy at the world’s largest Biotechnology Conference – San Diego, June 19- 23, 2017

Read more

Symposium on Liquid Biopsies & Cancer

Read more

MDxHealth and Queensland University of Technology Collaborate on Oral Cancer Liquid Biopsy Test

Read more

BCCM training: New developments in gene and plasmid technology

Read more

Biocartis Group NV: Biocartis and A*STAR's ETPL initiate development of breast cancer assay to guide therapy selection

Read more

New ThromboGenics' Ocriplasmin Clinical and Health Economic Data Presented at ASRS 2017 Annual Scientific Meeting in Boston

Read more

Scientists unravel role of glutamine synthetase in the spread of cancer

Read more

ONCURIOUS NV acquires unique portfolio of next-generation immuno-oncology assets from VIB

Read more

ThromboGenics Business Update - H1 2017

Read more

flanders.bio - CMAST Partner Day: Realizing Life Science Innovation with Impact

Read more

ONTOFORCE and akcelis collaborate to create and share infographics

Read more

Chemcys 2018

Read more

ThromboGenics announces publication in Experimental Eye Research of preclinical data supporting therapeutic potential of THR-317 in DR

Read more

Dinner with Chef Watson

Read more

Seminar: How Real World Data will change your clinical development to the better

Read more

TiGenix granted Orphan Drug Designation from the U.S. FDA for Cx601

Read more

argenx reports third quarter 2017 financial results and provides business update

Read more

International recognition for Dirk Inzé

Read more

MDxHealth Nine Month Trading Update

Read more

Biocartis Group NV: Idylla(TM) Performance Data Presented by US Key Opinion Leaders at Association for Molecular Pathology 2017 Conference

Read more

Ablynx announces results for the first nine months of 2017 and a year-to-date business update

Read more

Mindbytes initiates oncology R&D program focused on patient empowerment and is selected as one of five finalists for Astellas Oncology C3 Prize®

Read more

Celyad Announces Third Quarter 2017 Business Update

Read more

TiGenix to present positive 52-week Phase III Cx601 data at EHA-SWG Scientific Meeting

Read more

Promethera Biosciences Provides Update on Executive Management Team

Read more

Biocartis launches CE-marked IVD RAS liquid biopsy tests developed under partnership with Merck KGaA, Darmstadt, Germany

Read more

reMYND enters into license agreement with Novo Nordisk

Read more

BIO Asia International Conference

Read more

European funding in Health workshop – looking for your idea!

Read more

Ablynx announces board changes

Read more

VIB, CD3 and Galapagos NV enter into a license deal for the development of MALT1 inhibitors

Read more

Scientists shed light on a key molecular mechanism of autoimmune and inflammatory diseases

Read more

MDxHealth (R): Develops Blood Test to Guide Precision-Treatment of Castration-Resistant Prostate Cancer Patients

Read more

Sanofi to acquire Ablynx for €3.9 Billion

Read more

IMPACT of the Bio Base Europe Pilot Plant in industrial biotechnology

Read more

Ablynx announces 2017 full year results

Read more

MDxHealth financial results

Read more

Counteracting the effects of TNF receptor-1 has therapeutic potential in Alzheimer’s disease

Read more

flanders.bio - Janssen Pharma Partner Day 2018: Innovate – Connect – Collaborate!

Read more

Convert Pharmaceuticals secures EUR 13,6 million to develop anti-cancer drugs

Read more

MDxHealth contract SelectMDx with Roman Hospital

Read more

argenx reports fourth quarter business update and full year 2017 financial results

Read more

Biocartis announces 2017 results and 2018 outlook

Read more

CMAST to participate in the bio-europe spring partnering conference

Read more

BCCM training on preservation of micro-organisms

Read more

VIB: Molecular details of protein crystal nucleation uncovered

Read more

ThromboGenics announces publication in The Journal of Medicinal Chemistry of preclinical data

Read more

VIB presents its 2017 annual results and confirms its reputation as global player

Read more

MDxHealth Provides First Quarter 2018 Business Update

Read more

Biocartis Q1 2018 business update

Read more

Daily newsflash - 03/05/2018

Read more

Seminar Financial Accounting and Audit in European Research & Development Funding

Read more

argenx reports first quarter 2018 financial results and provides business update

Read more

flanders.bio Ghent becomes biotechnology capital of europe

Read more

GST raises EUR 5 million to develop veterinary stem cell products

Read more

CMAST presents new website and look & feel at Europe’s 2nd largest life sciences conference

Read more

Innovation Platforms & Projects

Read more

MDxHealth's SelectMDx Test Successfully Stratifies Men

Read more

argenx receives second preclinical milestone payment under its development agreement with AbbVie

Read more

Biogazelle appoints Armin Winands as new CEO

Read more

Biocartis launches innovative Idylla(TM) MSI Assay

Read more

MorphoSys and Galapagos Sign Global License Agreement for MOR106 with Top Pharma Partner

Read more

Dr. Margo Roberts joins Celyad’s Board of Directors and Scientific Committee

Read more

ISTA Congress London

Read more

OCTIMET Oncology NV awarded €1.077 million R&D grant from VLAIO

Read more

flanders.bio offers a wide range of advantages and services to its members

Read more

CMAST is stepping into a strategic partnership with FlandersBio

Read more

MDxHealth Epigenetic Biomarkers Identify Men at Increased Risk of Prostate Cancer Recurrence

Read more

BioBase4SME Natural Fibertastic Workshop aims to encourage SMEs to apply for fully funded Bio-Innovation Coupons for fibre application testing

Read more

Biocartis Group NV: Biocartis establishes US subsidiary and appoints US General Manager

Read more

Member Directory

Read more

The Future of Health Technology: Lab on Chip & Diagnostics platform meeting

Read more

knowledge for growth 2017

Read more

Argenx launches Phase II study of ARGX-110 as a monotherapy in relapsed/refractory CTCL patients

Read more

Academia-Industry Connect Meeting: Knowledge Valorisation: Matching science and market needs

Read more

RegMed

Read more

Symposium on Sepsis

Read more

2017 IIBN Forum - Biotechnology: from Innovation to Industrial Production

Read more

13th International Conference on Renewable Resources & Biorefineries

Read more

At The Forefront Of Plant Research

Read more

Nordic Life Science Days 2017

Read more

Next-Generation Antibodies and Protein Analysis (2nd Edition) - A VIB TOOLS & TECHNOLOGIES CONFERENCE

Read more

Bootcamp in Entrepreneurial Innovation in Orphan Diseases

Read more

Specialized blood vessels enhance tumor-fighting immunotherapy

Read more

argenx receives first preclinical milestone payment in AbbVie collaboration

Read more

Genohm releases the new version v5.4 of SLims

Read more

Nieuws van de dag - 25/04/2017

Read more

Flanders @ BIOJapan 2017: Flemish Life Sciences & Biotech Week

Read more

Biocartis Group NV: Biocartis Q1 2017 Business Update

Read more

Celyad initiates second dose escalation in THINK trial in first US patient

Read more

Nieuws van de dag- 4/05/2017

Read more

TiGenix Cx601 positive long-term results to be presented at Digestive Disease Week

Read more

Esperite (ESP), The Cell Factory demonstrate anti-inflammatory mode of action of CF-MEV-117 extracellular vesicle drug candidate for Epilepsy

Read more

Galapagos presents three posters on filgotinib in Crohn's disease at DDW® 2017

Read more

MDxHealth Trading Update: January to April 2017

Read more

Pauwels Consulting neemt Vandycke & Partners en Mediconsult over

Read more

TiGenix to present at the Crohn's and Colitis Foundation's Novel Technologies in Inflammatory Bowel Disease workshop in New York

Read more

FDA grants Fast Track Designation for Celyad’s ischemic heart failure therapy, C-Cure®

Read more

ThromboGenics Business Update - Q1 2017

Read more

Mithra to Initiate PK Study for Estelle®

Read more

Galapagos NV: Seven abstracts on filgotinib accepted by EULAR 2017

Read more

Market of 105 billion euros open to Flemish biotech companies

Read more

Ecosynth moves to new laboratories

Read more

Nieuws van de dag- 18/05/2017

Read more

Mithra Receives GMP Approval for Myring™ Production

Read more

Biocartis Group NV: Biocartis launches CE-marked IVD NRAS test for colorectal cancer

Read more

Bone Therapeutics strengthens Board with the appointments of Steve Swinson and Damian Marron as Non-Executive Directors

Read more

Cochlear acquires exclusive licence to Artificial Intelligence assistant

Read more

Biocartis wins prestigious Galenus Prize with its Idylla(TM) NRAS-BRAF Mutation Test for colorectal cancer

Read more

ThromboGenics to Present the Industry Pipeline of DME Treatments

Read more

TiGenix announces final equity payment for cardiac platform acquisition

Read more

argenx presents update on Phase I data from ARGX-110 expansion study in patients with cutaneous T-cell lymphomas

Read more

Daily Newsflash- 14/06/17

Read more

TiGenix Partners with U.S. and European Patient Advocacy Groups Focused on Crohn’s Disease and Ulcerative Colitis

Read more

Daily Newsflash- 15/06/2017

Read more

Celyad reports promising early results at first dose level of the solid arm of the THINK trial

Read more

Aphea.Bio aims at leading position in next generation agricultural biologicals

Read more

Swissmedic has accepted for review the file on Cx601 for the treatment of Crohn's disease patients

Read more

argenx receives second preclinical milestone payment in collaboration with LEO Pharma

Read more

Mithra Successfully Raises €26.1 Million

Read more

Daily Newsflash- 23/06/17

Read more

Ablynx achieves second milestone in immuno-oncology collaboration with Merck & Co., Inc., Kenilworth, New Jersey, USA

Read more

Mithra Signs Exclusive License and Supply Agreement with Fuji Pharma for Donesta® in Japan and Asean

Read more

Leadership Seminar: Wednesdays in the Summer: Why DNA and Talent do matter

Read more

Membership Information

Read more

Mithra Strengthens E4 Patent Position in Australian Market

Read more

BioInvent and ThromboGenics Amending Long-Standing Monoclonal Antibody Development Agreement

Read more

Mithra Submits Myring™ for European Marketing Approval

Read more

Celyad announces initiation of the SHRINK trial

Read more

iTeos Therapeutics Granted EUR 7.5 Million Non-Dilutive Funding by the Walloon Region

Read more

Interreg 2 Seas Project DERMA Industrial Matchmaking and Showcase Event

Read more

Mithra: Recruitment Completed in Estelle® Population PK Substudy

Read more

Navigation and spatial memory: new brain region identified to be involved

Read more

Mithra Announces First Subject Completes Estelle® Phase III Study

Read more

GREEN-CHEM: towards small footprint solutions

Read more

argenx announces publication of preclinical data supporting the therapeutic potential of SIMPLE AntibodyTM ARGX-116

Read more

argenx reports second quarter business update and half-year 2017 financial results

Read more

Ablynx announces 2017 half year results and year-to-date business update

Read more

Genohm at the Global Biobank Week in Stockholm

Read more

Press Release - Life Sciences & Biotechnology

Read more

Mindbytes expands to North America to develop next generation serious medical games driven by artificial intelligence

Read more

TiGenix obtains commercial production license for expanded manufacturing facility

Read more

Biocartis Group NV: Idylla(TM) Respiratory (IFV-RSV) Panel receives 510(k) clearance by US FDA

Read more

Genohm announced today the signing of several new clients

Read more

Biocartis announces H1 2017 results

Read more

SelectMDx Outperforms PCA3 Stratifying Men for mpMRI

Read more

PharmaFluidics appoints Fasha Mahjoor as independent director

Read more

TiGenix strengthens US operations with senior appointments

Read more

Flanders @ Naturejobs Career Expo - Düsseldorf

Read more

Expertise - FUND

Read more

ThromboGenics Regains Global Rights to JETREA® (ocriplasmin)

Read more

Mithra announces 2017 half year results

Read more

Expertise

Read more

Bone Therapeutics and Asahi Kasei sign exclusive license agreement for PREOB® in Japan

Read more

Trainings - CONNECT / EDUCATE

Read more

eTheRNA immunotherapies awarded €1 million grant from Flanders Innovation & Entrepreneurship

Read more

ThromboGenics Presenting THR-687 Preclinical Data at European Association for Vision and Eye Research (EVER) Meeting

Read more

TiGenix to participate and present at key investor and business development meetings

Read more

ThromboGenics Successfully Introduces New 'Already-Diluted' Formulation of JETREA® (ocriplasmin) in the US

Read more

BioFIT 2017

Read more

Key Considerations in Health Care Product Development

Read more

Mithra’s Marketing Authorization Application for Tibelia® Accepted by Health Canada

Read more

Mithra Announces Completion of Recruitment in Donesta® Phase II Study

Read more

GAMIAN-Europe & CMAST announce collaborative partnership

Read more

MyCartis appoints Philippe Stas as CEO

Read more

Mithra Completes Recruitment for Estelle® Phase III Study in US and Canada

Read more

Mithra Announces Launch of Warrant Exercise Period

Read more

OCTIMET Oncology NV awarded €1.12 million grant from VLAIO

Read more

ThromboGenics Strengthens Leadership Team

Read more

Laborama 2018

Read more

Mithra Announces Positive Outcome of Myring™ Commercial Batch Bioequivalence Study

Read more

Mithra Announces 36-month Shelf Life Extension for Tibelia®

Read more

A Practical Guide to MiFID II

Read more

Publication of a Transparency Notification Received by Mithra Pharmaceuticals sa/nv

Read more

Mithra Confirms Conversion of Subscription Rights

Read more

Mithra Provides Update on Estelle® and Donesta® Studies

Read more

Follow-up info flanders.bio-CMAST Partner Day

Read more

Medical Biotechnology

Read more

Mithra Announces Valorization of French Subsidiary

Read more

7/12/2017

Read more

Patient Enrolment in Phase II CIRCLE Study Evaluating THR-409 (ocriplasmin) for Non-Proliferative Diabetic Retinopathy (NPDR) Discontinued due to Slow Recruitment Rate

Read more

argenx to provide updates on Phase 1/2 clinical trials of ARGX-110 in Acute Myeloid Leukemia and Cutaneous T-Cell Lymphoma during American Society of Hematology Annual Meeting

Read more

Expertise - 10/01/2018

Read more

Press Release - Life Sciences & Biotechnology - 14/12/2017

Read more

ChinaBio Partnering Forum 2018

Read more

Mithra Announces Injectables Agreement with GSP

Read more

Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease

Read more

TiGenix confirms strategic focus on Cx601 and its adipose derived stem cell (eASC) platform

Read more

Trainings

Read more

Rewind Therapeutics secures 15.2 M EURO to develop novel remyelination therapies

Read more

PharmaFluidics raises 7.3 million euro to expand commercialization of novel micro-chip device for biomarker, diagnostics and drug development applications

Read more

Mithra Announces Last Subject Completes Donesta® Phase II Study

Read more

Networking - 01/03/2018

Read more

Press Release - Life Sciences & Biotechnology - 2/02/2018

Read more

Colli-Pee recognized at the prestigious Henry Van de Velde Awards

Read more

Acacia Pharma announces its intention to launch an initial global offering and to list its shares on Euronext Brussels

Read more

Mithra announces very promising hemostasis results for Estelle®

Read more

Networking - 01/03/2018

Read more

flanders.bio's flagship event knowledge for growth 2018

Read more

Service - 20/02/2018

Read more

Galapagos and MorphoSys present results from a Phase 1 study with MOR106 in atopic dermatitis as late-breaking abstract at the American Academy of Dermatology (AAD) meeting in San Diego

Read more

Key Considerations in Health Care Product Development

Read more

Networking - 28/02/2018

Read more

Mithra Reports 2017 Annual Results

Read more

Mithra presents positive hemostasis results at ISGE conference

Read more

MedFIT - Fostering Innovation in medTech

Read more

Nordic Life Science Days 2018

Read more

BioFIT 2018

Read more

Networking

Read more

Networking - 28/02/2018

Read more

Daily newsflash - 19/03/2018

Read more

Mithra Announces Completion of Estelle® Cycles Required in Phase III Contraception Studies

Read more

Networking - 01/03/2018

Read more

CMAST to present at a Veeva seminar on modernizing quality management / April 10th, 2018 / Paris, France

Read more

ThromboGenics Reports Initial Data from its Clinical Study evaluating THR-317, an anti-PlGF, for the Treatment of Diabetic Macular Edema (DME)

Read more

Mithra signs principle agreement for commercialization of Estelle® in canada

Read more

Mithra releases 2017 Annual Report and invitation to its Ordinary General Shareholders' Meeting

Read more

Daily newsflash - 24/04/2018

Read more

Networking - 14/06/2018

Read more

Galapagos and MorphoSys announce initiation of the IGUANA Phase 2 clinical trial with MOR106 in atopic dermatitis patients

Read more

Information regarding Belgian biobank law and international standards

Read more

Press Release - Life Sciences & Biotechnology - 15/05/2018

Read more

Mithra announces injectable contract with Midas Pharma

Read more

Press Release - Life Sciences & Biotechnology - 23/05/2018

Read more

The first annual Benelux Precision Medicine Forum

Read more

Webinar: A comprehensible jumpstart towards gcp computer system validation anno 2018

Read more

Update on mithra and mayne pharma’s vaginal contraceptive ring opportunity

Read more

Networking - 14/06/2018

Read more

CMAST to participate in the bio international convention (Boston, us - 4-7 june, 2018)

Read more

Mithra launches capital increase by means of a private placement via an accelerated bookbuild offering

Read more

Mithra successfully raises eur 77.5 million

Read more

Gilead and Galapagos announce results with filgotinib in the phase 2 equator study in psoriatic arthritis and progression into phase 3 for the selection study in ulcerative colitis

Read more

Mithra signs binding heads of terms for commercialization of Estelle® in South Korea with women's health specialist Hyundai Pharm

Read more

SYMPOSIUM: Immuno-Oncology and Inflammation; Discovering New Scientific Frontiers

Read more

Mithra: information on the total number of voting rights

Read more

Takeda and TiGenix Announce Results of First Acceptance Period for the Voluntary and Conditional Public Takeover Bid of TiGenix and Commencement of Second Acceptance Period

Read more

Mithra Announces Presentation of Donesta® Results at the International Menopause Society’s 16th World Congress

Read more

flanders.bio - Roche Diagnostics Partner Day 2018: ’Towards high-quality Cell Therapy’

Read more

The first veterinary stem cell product recommended for approval in Europe becomes a reality

Read more

Flanders @ BIOJapan 2018: Flemish Life Sciences & Biotech Week

Read more

Mithra: Publication of a Transparency Notification Received from François Fornieri

Read more

Takeda and TiGenix Announce Results of Second Acceptance Period for the Voluntary and Conditional Public Takeover Bid in respect of TiGenix

Read more

Galapagos announces design for PINTA Phase 2 trial with GLPG1205 in IPF

Read more

International Conference on Industrial Biotechnology and Bioprocessing

Read more

Mithra and Mediner sign LSA for Tibelia® in Hungary

Read more

ELIXIR Innovation and SME Forum

Read more

Mithra Obtains First Marketing Authorization for Myring™ in Europe

Read more

Mithra announces belux agreement with ceres pharma worth over eur 40 million

Read more

The FAMPH has published the Compendium on Biobank legislation

Read more

Mithra announces positive top-line results of estelle® phase III oral contraceptive study in eu/russia

Read more

Press Release - Life Sciences & Biotechnology - 10/08/2018

Read more